Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,751
Closed -$438K 245
2023
Q2
$438K Buy
7,751
+272
+4% +$15.1K 0.11% 170
2023
Q1
$437K Sell
7,479
-437
-6% -$29.5K 0.11% 172
2022
Q4
$497K Sell
7,916
-1,211
-13% -$86.7K 0.14% 149
2022
Q3
$567K Buy
9,127
+1,211
+15% +$77.4K 0.17% 138
2022
Q2
$496K Buy
7,916
+125
+2% +$8.28K 0.14% 149
2022
Q1
$550K Buy
7,791
+735
+10% +$49.7K 0.14% 155
2021
Q4
$440K Hold
7,056
0.1% 184
2021
Q3
$433K Sell
7,056
-240
-3% -$14.4K 0.11% 185
2021
Q2
$437K Buy
7,296
+35
+0.5% +$2.22K 0.11% 186
2021
Q1
$444K Buy
7,261
+526
+8% +$29K 0.12% 174
2020
Q4
$314K Buy
6,735
+6,391
+1,858% +$277K 0.09% 204
2020
Q3
$223 Buy
+344
New +$13.1K ﹤0.01% 409
2020
Q1
Sell
-45,150
Closed -$2.3M 236
2019
Q4
$2.3M Buy
+45,150
New +$2.18M 0.85% 30

Other funds holding MET

Summit X LLC's MET Position: Q3 2023 in Review

Summit X LLC sold out of MetLife (MET) in Q3 2023, closing a stake of 7,751 shares — an estimated $438K sold.

Summit X LLC first reported a position in MET in Q4 2019 and held it in 13 quarters. The position peaked at $2.3M in Q4 2019. 1,180 funds tracked by Wall St. Rank hold MET as of Q3 2023.

  • Summit X LLC reported no remaining MetLife position as of Q3 2023 after selling out during the quarter.
  • Summit X LLC sold 7,751 MetLife shares in Q3 2023, an estimated $438K.
  • Summit X LLC first reported a position in MetLife in Q4 2019 and held it in 13 quarters.
  • Summit X LLC's MetLife position peaked at $2.3M in Q4 2019.
  • 1,180 funds tracked by Wall St. Rank held MetLife as of Q3 2023.

Based on Summit X LLC's 13F filing for Q3 2023, filed 6 Nov 2023.